Stay updated on Nivolumab in Refractory Biliary Tract Cancers Clinical Trial

Sign up to get notified when there's something new on the Nivolumab in Refractory Biliary Tract Cancers Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Nivolumab in Refractory Biliary Tract Cancers Clinical Trial page

  1. Check
    7 days ago
    No Change Detected
  2. Check
    14 days ago
    Change Detected
    Summary
    Revision history updated to add v3.5.0 and remove v3.4.3.
    Difference
    0.1%
    Check dated 2026-03-20T04:29:44.000Z thumbnail image
  3. Check
    21 days ago
    Change Detected
    Summary
    New update dates for 2026 (2026-03-11, 2026-02-26, 2026-02) were added and older December 2025 dates were removed.
    Difference
    0.2%
    Check dated 2026-03-12T22:37:11.000Z thumbnail image
  4. Check
    29 days ago
    Change Detected
    Summary
    Added Moffitt Cancer Center Clinical Trials website and the institution name (H. Lee Moffitt Cancer Center and Research Institute) and included Helpful Links. Updated the site revision from v3.4.2 to v3.4.3.
    Difference
    0.2%
    Check dated 2026-03-05T18:53:20.000Z thumbnail image
  5. Check
    43 days ago
    Change Detected
    Summary
    The sponsor center name and the 'Helpful Links Provided by' block were removed from the study page.
    Difference
    0.2%
    Check dated 2026-02-19T05:29:38.000Z thumbnail image
  6. Check
    50 days ago
    Change Detected
    Summary
    Footer revision updated: added Revision: v3.4.2 and removed Revision: v3.4.1.
    Difference
    0.1%
    Check dated 2026-02-12T02:45:54.000Z thumbnail image
  7. Check
    57 days ago
    Change Detected
    Summary
    Revision tag updated from v3.4.0 to v3.4.1 on the page. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2026-02-05T00:52:07.000Z thumbnail image

Stay in the know with updates to Nivolumab in Refractory Biliary Tract Cancers Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Nivolumab in Refractory Biliary Tract Cancers Clinical Trial page.